SU 4981

CAS No. 186610-88-8

SU 4981( 3-(4-Morpholinobenzylidene)indolin-2-one )

Catalog No. M28540 CAS No. 186610-88-8

SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 173 In Stock
5MG 174 In Stock
10MG 258 In Stock
25MG 392 In Stock
50MG 539 In Stock
100MG 723 In Stock
200MG 958 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU 4981
  • Note
    Research use only, not for human use.
  • Brief Description
    SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.
  • Description
    SU 4981 is an inhibitor of VEGFR and a modulator of tyrosine kinase activity.
  • In Vitro
    hVEGF-IN-2 (0-100 μM) shows the inhibitory activities to particular RTKs at the cellular level with IC50 values of 2.5, 33.1, >100, >100 and >100 nM for VEGF, PDGF, EGF, HER-2 and IGF-1, respectively.
  • In Vivo
    ——
  • Synonyms
    3-(4-Morpholinobenzylidene)indolin-2-one
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    Antioxidant|VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186610-88-8
  • Formula Weight
    306.36
  • Molecular Formula
    C19H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC=2C=CC=CC2C1=CC3=CC=C(C=C3)N4CCOCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Afifi FU, Aburjai T. Antiplatelet activity of Varthemia iphionoides. Fitoterapia. 2004 Dec;75(7-8):629-33.
molnova catalog
related products
  • Vatalanib

    A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.

  • Ranibizumab

    Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A.

  • SU14813

    A broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.